Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
On January 28, 2022, Douglas R. Carlson informed Ikena Oncology, Inc. (the
"Company") of his intent to resign as Chief Operating Officer and Executive Vice
President of Finance of the Company to pursue other professional opportunities
with broader responsibility. Mr. Carlson's resignation will be effective on
February 18, 2022. Francisco Oliveira, the Head of Finance and Administration
since 2019, will serve as Principal Accounting Officer and report directly to
the Company's Chief Executive Officer, Mark Manfredi, on an interim basis
effective as of Mr. Carlson's departure, while a formal search process to
appoint a new Chief Financial Officer is conducted.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses